Safety Alerts & Recalls
What does this mean?
At this time there have been no reports of health problems linked to this recall. This recall for Ranitidine Tablets,150 mg was issued at a warehouse/pharmacy level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. However, you may wish to check your medication - if any of your tablets look bigger than normal or if they look different than what you normally receive, take your prescription to your pharmacist to examine.
If you take Ranitidine Tablets, 150 mg and have any concerns, you should consult with your physician.
Recall on a Single Lot of Ranitidine Tablets, 150 mg
Amneal Pharmaceuticals is recalling a single lot of Ranitidine Tablets, 150 mg. Lot number HE14509 is being recalled because of two reports of oversized tablets - one of these oversized tablets contained one and a half times more of the active ingredient than what is stated on the product label.
Ranitidine is used in the treatment of ulcers, gastroesophageal reflux disease (GERD), and esophagitis. Ranitidine is also sold under the brand name Zantac. No other lots, strengths, or brands of ranitidine were involved in this recall.
For more information, please visit: more information here